Microsoft (MSFT) managed to beat Wall Street earnings estimates for its fiscal first quarter, reporting earnings of $2.35 a share versus the $2.29 expected by analysts after the market close on October 25. But the stock is down strongly today, October 26, on the company’s forecast of slowing growth for the next quarter and a decline in growth from its Intelligent Cloud business unit.
Today I posted my one-hundred-ninety-sixth YouTube video: Trend of the Week Seasonal Trends in Energy. This week’s Trend of the Week: Seasonal Trends in Energy. There’s a predictable pattern in oil and natural gas prices. In late fall, October to November, you can expect a deep dive to begin and carry on through the winter, with a sharp rise in March and early spring. You can see this trend looking at previous years in the United States Oil Fund (NYSEARCA: USO) and the United States Natural Gas Fund, LP (NYSEARCA: UNG). Right now, we’re heading into that dip in energy prices but you should not sell – in fact, you should be adding to these positions. This seasonal fall in energy prices will allow you to get ahead of the spring bounce. Europe’s energy supply is enough to get through the upcoming winter but, in March, as they look toward next year’s supply, they’ll need to start rebuilding inventories in a market strained by the war in Ukraine, cuts in production, and a hostile OPEC. Stateside, the US Energy Information Administration is projecting record production from the Permian Basin of Texas and Oklahoma, as well as record production of natural gas this year. Even though we’re not seeing a whole lot of capital expenditure, they’re uncapping wells and pumping them harder. Look at USO and UNG as ETF oil and natural gas buys For individual stocks I’d look at Pioneer Natural Resources (NYSE: PXD), ConocoPhillips (NYSE: COP), and EQUINOR (NYSE: EQNR)–all of which I own in portfolios and have no intention of selling anytime soon.
This morning before the stock market open Coca-Cola reported earnings of 69 cents a share for the third quarter. That was up from 65 cents a share in the third quarter of 2021 and was above the 64 cents a share expected by Wall Street analysts. Revenue of $11.1 billion was higher than the $10.5 billion projected by Wall Street.
On Monday on my subscription JubakAM.com site, I made Lynas Rare Earths (LYSDY) the eighth pick in my Special Report: 9 Picks to Make Money in This Bear Market and said that I would add it to the Jubak Picks Portfolio today. This is what I wrote in my Special Report: “This isn’t a Fed pick, an economic growth pick, or a Bear Market bottom pick. It’s a straightforward U.S.-China trade war pick
If you liked the Trump administration’s trade war with China, you’ll love the Biden administration’s new, more dangerous, escalated version. Rather than slapping tariffs on Chinese goods, and inviting retaliatory tariffs by China on American products, the Biden administration war limits the same of advanced semiconductors and chip-making equipment to Chines companies. The action is aimed straight at the heart of China’s efforts to build its own chip industry. And it plays right into a belief, stoked by China’s President Xi Jinping, that China is the victim of a Western plot to prevent the country’s rise to its rightful place in the global order. And the opening blows in this trade war come just as President Xi aims to be installed as China’s newest preeminent leader with a status near that of Mao. I don’t know what the retaliation from China will be, but it is unlikely to stop with a few restrictions on how U.S. companies, such as Tesla (TSLA) and Apple (AAPL) operate in China. The situation is so dangerous because it is so uncertain and so open-ended.
After the market close on October 5, Costco Wholesale (COST) reported that sales for September had climbed 10.1% to $21.46 billion. Total same-store sales rose 8.5% in September, beating Wall Street’s estimate of 6.3% growth.
I added Freyr Battery to my 10 Perfect Stock Special Report today. Tomorrow I’m adding the stock to my Jubak Picks Portfolio with a target price of $21 a share. This is what I wrote about Freyr in my Special Report.
Yesterday I added General Motors to my 10 Perfect Stock Picks Special Report. Here’s what I wrote in that Special Report on the buy.
Is there such a thing as a perfect stock? Depends. Not a chance, if you mean a stock that will be perfect in every market for every time period. No way, if you mean a stock that will go up steadily from the day you buy it. Nah, if you mean a “Buy and Hold Forever Stock.” But there are stocks that are “perfect” for a specific kind of market. And there are stocks that are “perfect” for a specific holding period. And there are stocks that are “perfect” for investors with a specific portfolio goal. And in this Special Report, I’m going to give you 10 of those Perfect Picks.
Apple (AAPL), which once urged suppliers to increase production of its new iPhone, is now telling them “Never mind,” according to Bloomberg. The anticipated surge in demand has failed to materialize. the company had told suppliers to increase production in the second half of the year ahead of a projected increase in iPhone sales in the second half of 2022. Now Apple is aiming to produce 90 million iPhones in the period. That’s roughly the same level as in the second half of 2021 and in line with Apple’s original forecast this summer.
Shares of Eli Lilly (LLY), a pick for my Jubak Pick’s Portfolio in a post yesterday, are up 8.89% today as of noon New York time, September 28, on news that an experimental Alzheimer’s drug from Biogen (BIIB) and Japan’s Eisai(ESALY) slowed cognitive and functional decline by 27 percent in a clinical trial. Today shares of Biogen are up 38.07% and shares of Eisai are up 62.6% on the news. Why the pop in Lilly? As I explained in my post yesterday, Lilly has its own Alzheimer’s drug in development and positive results out of Biogen/Eisai are thought to be a positive for that drug too.
I’m extremely reluctant to add any stocks to any portfolios right now. There’s just too much near-term uncertainty and we remain locked in the grip of a pushing Bear Market. But I do want to upgrade my portfolios when possible to increase their future upside. So tomorrow September 28, I’ll be adding shares of drug maker Eli Lilly (LLY) to my Jubak Picks Portfolio; To make this an upgrade rather than an addition to this portfolio, I will also be selling shares of biotech Incyte (INCY) out of that portfolio. In this paired trade I think I’m adding a comparatively stronger drug pipeline to my holdings.
